A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(6 sites)

United States

City of Hope, Duarte, California

California Cancer Associates for Research and Excellence, cCARE, San Marcos, California

Providence Saint John's Health Center, Santa Monica, California

Cleveland Clinic, Cleveland, Ohio

Mary Crowley Cancer Research, Dallas, Texas

MD Anderson Cancer Center, Houston, Texas